Clifford Chance has advised Heilpflanzenwohl AG on the deal. Heilpflanzenwohl AG finalized the acquisition of two OTC products, “Döderlein” and “Omniflora”, from Haleon Sarl. The project...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here